ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,709, issued on April 14, was assigned to CRINETICS PHARMACEUTICALS INC. (San Diego). "Nonpeptide somatostatin type 5 receptor agonists and... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,710, issued on April 14, was assigned to LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC. (Tampa, Fla.). "Beta-catenin and b-cell lym... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,711, issued on April 14, was assigned to KEZAR LIFE SCIENCES INC. (South San Francisco, Calif.). "Triazacyclododecansulfonamide (TCD)-base... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,712, issued on April 14, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.). "Amino-pyrimidine amides" was invented by Angelica B... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,713, issued on April 14, was assigned to Hutchmed Ltd. (Shanghai). "Crystalline forms of 6-((6,7-dimethoxyquinazolin-4-yl)oxy)-N,2-dimethy... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,714, issued on April 14, was assigned to WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) Co. LTD. (Shanghai). "Substituted pyrazinecarboxamide com... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,715, issued on April 14, was assigned to Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany). "Soluble guanylate cyclate... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,716, issued on April 14, was assigned to Gannex Pharma Co. Ltd. (Shanghai). "Compounds for modulating activity of FXR and uses thereof" wa... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,717, issued on April 14, was assigned to Incyte Corp. (Wilmington, Del.). "Tricyclic compounds as inhibitors of KRAS" was invented by Zhen... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,718, issued on April 14, was assigned to BORYUNG Corp. (Seoul, South Korea). "Method for preparing compound as PI3K inhibitor and intermed... Read More